The invention relates to the use of compounds of formula (I) or (II) in thetreatment of mammalian target ofVEGF-driven angiogenic diseases, methods of use of said compounds in thetreatment of said diseases in a warm-blooded animal,especially a human, pharmaceutical preparations comprising said compounds forthe treatment of said diseases and said compoundsfor use in the treatment of said diseases.